- Poster presentation
- Open Access
Papillary muscle native T1 time is associated with severity of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy
© Kato et al. 2016
- Published: 27 January 2016
- Mitral Regurgitation
- Papillary Muscle
- Multivariate Linear Regression Analysis
- Functional Mitral Regurgitation
- Quantify Blood Flow
Functional mitral regurgitation is one of the important complications of non-ischemic dilated cardiomyopathy (DCM). Non-contrast native T1 mapping enables non-invasive quantification of myocardial fibrosis. We sought to assess the potential relationship between papillary muscle T1 time and severity of mitral regurgitation in DCM patients.
Forty DCM patients (55 ± 13 years) and 20 healthy adult control subjects (54 ± 13 years) were enrolled. Slice interleaved T1 mapping sequence (STONE) was employed for the native T1 mapping, which enables acquisition of 5 slices in the short-axis plane within a 90 sec free-breathing scan. For calculating papillary muscle native T1 time, both anterior and posterior papillary muscles were manually traced on custom software (MediaCare, Boston, MA, USA). We measured papillary muscle diameter, length and shortening on cine MRI. Phase contrast images were acquired perpendicular to the proximal ascending aorta to quantify blood flow. Mitral regurgitation volume was calculated as the difference between the LV stroke volume and ascending aorta forward flow. DCM patients were allocated into 2 groups based on the presence or absence of functional mitral regurgitation.
Determinants for Severity of Functional Mitral Regurgitation in Non-ischemic Dilated Cardiomyopathy
95% CI for β
-0.061 - 0.049
-0.211 - 0.193
Mitral annulus (4 chamber), mm
-0.138 - 0.479
Tenting height, mm
0.434 - 2.234
Papillary muscle T1 time
0.048 - 0.170
In DCM, papillary muscle native T1 time is significantly elevated and related to mitral regurgitant fraction. These results suggest that papillary muscle diffuse fibrosis might be associated with severity of functional mitral regurgitation in this population.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.